Robin J Casten1, Barry W Rovner. 1. Department of Psychiatry and Human Behavior, Jefferson Medical College, Philadelphia, PA 19107, USA. Robin.Casten@jefferson.edu
Abstract
PURPOSE OF REVIEW: This review updates the literature on depression in age-related macular degeneration (AMD). Treatment for AMD has been revolutionized since the 2004 review of depression and AMD. New data describing the prevalence of depression in AMD, as well as novel interventions for managing depression in AMD, are discussed. RECENT FINDINGS: Depression continues to be prevalent in AMD and new information is available on the pathways by which impaired vision leads to depression. Strategies for the treatment of depression in patients with impaired vision have evolved. SUMMARY: AMD is still a major risk factor for depression and people with activity restriction due to vision loss are at greatest risk. An integrated approach to depression management in older adults with impaired vision may be the best course of action.
PURPOSE OF REVIEW: This review updates the literature on depression in age-related macular degeneration (AMD). Treatment for AMD has been revolutionized since the 2004 review of depression and AMD. New data describing the prevalence of depression in AMD, as well as novel interventions for managing depression in AMD, are discussed. RECENT FINDINGS:Depression continues to be prevalent in AMD and new information is available on the pathways by which impaired vision leads to depression. Strategies for the treatment of depression in patients with impaired vision have evolved. SUMMARY:AMD is still a major risk factor for depression and people with activity restriction due to vision loss are at greatest risk. An integrated approach to depression management in older adults with impaired vision may be the best course of action.
Authors: Barbara L Brody; Anne-Catherine Roch-Levecq; Anthony C Gamst; Kellie Maclean; Robert M Kaplan; Stuart I Brown Journal: Arch Ophthalmol Date: 2002-11
Authors: B L Brody; A C Gamst; R A Williams; A R Smith; P W Lau; D Dolnak; M H Rapaport; R M Kaplan; S I Brown Journal: Ophthalmology Date: 2001-10 Impact factor: 12.079
Authors: Tom H Margrain; Claire Nollett; Julia Shearn; Miles Stanford; Rhiannon Tudor Edwards; Barbara Ryan; Catey Bunce; Robin Casten; Mark T Hegel; Daniel J Smith Journal: BMC Psychiatry Date: 2012-06-06 Impact factor: 3.630
Authors: Hilde P A van der Aa; Mirke Hoeben; Linda Rainey; Ger H M B van Rens; Hilde L Vreeken; Ruth M A van Nispen Journal: Qual Life Res Date: 2014-11-15 Impact factor: 4.147
Authors: S Scott Whitmore; Elliott H Sohn; Kathleen R Chirco; Arlene V Drack; Edwin M Stone; Budd A Tucker; Robert F Mullins Journal: Prog Retin Eye Res Date: 2014-12-05 Impact factor: 21.198
Authors: Barry W Rovner; Robin J Casten; Mark T Hegel; Robert W Massof; Benjamin E Leiby; Allen C Ho; William S Tasman Journal: Ophthalmology Date: 2014-07-09 Impact factor: 12.079